Schrödinger Inc. (SDGR)
| Bid | 26.12 |
| Market Cap | 1.94B |
| Revenue (ttm) | 207.54M |
| Net Income (ttm) | -187.12M |
| EPS (ttm) | -2.57 |
| PE Ratio (ttm) | -10.34 |
| Forward PE | -9.07 |
| Analyst | Buy |
| Ask | 26.86 |
| Volume | 3,048,783 |
| Avg. Volume (20D) | 1,112,388 |
| Open | 24.85 |
| Previous Close | 24.49 |
| Day's Range | 24.31 - 26.86 |
| 52-Week Range | 16.60 - 28.47 |
| Beta | 1.77 |
About SDGR
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on...
Analyst Forecast
According to 7 analyst ratings, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $29.5, which is an increase of 10.96% from the latest price.
Stock Forecasts
3 weeks ago · businesswire.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company's common...
